Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industrye

Discrepancy between financial disclosures of authors of clinical practice guidelines and reports by industrye
复制标题

DOI:
10.1097/md.0000000000005711
复制
发表时间:
2017-01-01
期刊:
影响因子:
1.6
通讯作者:
Mylonakis, Eleftherios
Mylonakis, Eleftherios
中科院分区:
医学4区
文献类型:
--
作者:
Andreatos, Nikolaos;Zacharioudakis, Ioannis M.;Mylonakis, Eleftherios

文献摘要

被引文献

相似文献

我们正在努力提高利益冲突(COI)报告的准确性,并减少COI在医生和行业之间的影响,特别是在涉及临床实践指南的情况下。我们使用新实施的Open Payments数据集来评估临床实践指南作者的COI披露的准确性,这些指南是在2014年内新发布或修订的,并被纳入国家指南信息交换中心(NGC)网站(由美国卫生与公众服务部维护)。如果作者在指南发布前12个月没有报告他们获得资金的所有公司,他们被认为披露了不准确的COI。我们确定了223份指南,这些指南要么是在2014年新发布的(109/223;48.9%),要么是修订(114/223;51.1%),并被纳入NGC网站。在拥有Open Payments数据的1329名指南作者中,523人从至少一个与医疗保健相关的实体获得了5000美元。然而,在523名作者中,只有56名(10.7%)被发现有准确的COI披露。修订后的指南中准确披露COI的作者比例显著低于新发布的指南(6.8%比14.3%;P
There is a substantial effort to increase the accuracy of conflicts of interest (COI) reporting, and reduce the influence of COI between physicians and industry, especially as it relates to clinical practice guidelines.We used the newly implemented Open Payments dataset to evaluate the accuracy of COI disclosures of authors of clinical practice guidelines that were either newly published or revised within 2014 and were included in the National Guideline Clearinghouse (NGC) website (maintained by the U.S. Department of Health and Human Services). Authors were considered as having inaccurate COI disclosure if they had not reported all companies from which they had received funds >$5000 in the 12 months preceding the guideline's publication.We identified 223 guidelines that were either newly published (109/223; 48.9%) or revised (114/223; 51.1%) within 2014 and were included in the NGC website. Among the 1329 guideline authors with available Open Payments data, 523 received >$5000 from at least 1 healthcare-associated entity. However, only 56 out of the 523 authors (10.7%) were found to have accurate COI disclosure. The percentage of authors with accurate COI disclosure in revised guidelines was significantly lower than in newly published guidelines (6.8% vs 14.3%; P